ArticleFrontiers in medicine2025
Observation of the effect of intensity-modulated radiotherapy combined with microwave diathermy on tumor marker levels and prognosis in cervical cancer.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to explore the effects of intensity-modulated radiation therapy (IMRT) combined with microwave diathermy (MWD) on tumor marker levels and prognosis in patients with cervical cancer. Methods: A retrospective analysis was conducted on the clinical data of 121 cervical cancer patients admitted to our hospital from April 2021 to April 2023. Among them, 59 patients received IMRT alone (IMRT group), while 62 patients received IMRT combined with MWD treatment (combination group). Comparison of disease control rates, serum tumor marker levels before and after treatment, quality of life (QoL), and prognosis between the two groups. Results: The combination group achieved a significantly higher disease control rate (88.71%) than the IMRT group (74.58%). After treatment, serum levels of carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCCA), and carbohydrate antigen 50 (CA50) were significantly lower in the combination group than in the IMRT group ( Conclusion: Compared to IMRT alone, the combination of IMRT and MWD treatment for cervical cancer patients can significantly downregulate tumor markers and levels of TGF-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.